A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Sacituzumab Tirumotecan Plus Anlotinib for Metastatic Triple Negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Phase II Trial Evaluating the Safety and Efficacy of the Combination of Zimberelimab, Domvanalimab and Sacituzumab Govitecan as 1L Therapy for PD-L1 Positive Advanced TNBC
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Patterns of Care and Outcomes in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Feasibility of Serial Multisite Image-guided Biopsy to Study Breast Cancer Evolution
- Status
- RECRUITING
- Phase
- N/A
Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC
- Status
- RECRUITING
- Phase
- NA
Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of LY4175408 in Participants With Advanced Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Status
- RECRUITING
- Phase
- PHASE1
Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Stromal Tumor-Infiltrating Lymphocyte Levels Are Associated With Immune Checkpoint Proteins In Triple Negative Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
Trilaciclib Combined With Anti-PD-1 Antibody and Chemotherapy in the Treatment of Locally Advanced TNBC
- Status
- RECRUITING
- Phase
- PHASE2
Investigating Datopotamab Deruxtecan Plus Durvalumab Versus Datopotamab Deruxtecan in Patients With PDL1-negative Metastatic Triple-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2